首页> 美国卫生研究院文献>Oncotarget >A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery
【2h】

A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery

机译:基于人工神经网络的评分系统用于预测根治性手术后II A期结肠癌患者的10年生存率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nearly 20% patients with stage II A colon cancer will develop recurrent disease post-operatively. The present study aims to develop a scoring system based on Artificial Neural Network (ANN) model for predicting 10-year survival outcome. The clinical and molecular data of 117 stage II A colon cancer patients from Sun Yat-sen University Cancer Center were used for training set and test set; poor pathological grading (score 49), reduced expression of TGFBR2 (score 33), over-expression of TGF-β (score 45), MAPK (score 32), pin1 (score 100), β-catenin in tumor tissue (score 50) and reduced expression of TGF-β in normal mucosa (score 22) were selected as the prognostic risk predictors. According to the developed scoring system, the patients were divided into 3 subgroups, which were supposed with higher, moderate and lower risk levels. As a result, for the 3 subgroups, the 10-year overall survival (OS) rates were 16.7%, 62.9% and 100% (P < 0.001); and the 10-year disease free survival (DFS) rates were 16.7%, 61.8% and 98.8% (P < 0.001) respectively. It showed that this scoring system for stage II A colon cancer could help to predict long-term survival and screen out high-risk individuals for more vigorous treatment.
机译:接近20%的II A期结肠癌患者将在术后复发疾病。本研究旨在开发一种基于人工神经网络(ANN)模型的评分系统,以预测10年生存期。采用中山大学肿瘤防治中心117例ⅡA期结肠癌患者的临床和分子数据作为训练集和测试集。病理分级差(得分49),TGFBR2表达降低(得分33),TGF-β过表达(得分45),MAPK(得分32),pin1(得分100),β-catenin在肿瘤组织中的得分(得分50) )和正常黏膜中TGF-β的降低表达(评分22)被选为预后风险预测指标。根据发达的评分系统,将患者分为3个亚组,分别具有较高,中度和较低的风险水平。结果,这三个亚组的10年总生存率分别为16.7%,62.9%和100%(P <0.001)。和10年无病生存率(DFS)分别为16.7%,61.8%和98.8%(P <0.001)。结果表明,这种针对IIA期结肠癌的评分系统可以帮助预测长期生存率,并筛选出高风险个体以进行更积极的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号